Is Neptune Wellness Solutions Inc (NEPT) a Winner in the Drug Manufacturers - Specialty & Generic Industry?

Monday, June 29, 2020 9:53 AM | InvestorsObserver Analysts

A rating of 92 puts Neptune Wellness Solutions Inc (NEPT) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Neptune Wellness Solutions Inc's score of 92 means it scores higher than 92% of stocks in the industry. Neptune Wellness Solutions Inc also received an overall rating of 63, putting it above 63% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 128 out of the 148 industries.

Overall Score - 63
NEPT has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on NEPT!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Neptune Wellness Solutions Inc Stock Today?

Neptune Wellness Solutions Inc (NEPT) stock is higher by 2.11% while the S&P 500 is unmoved 0% as of 9:52 AM on Monday, Jun 29. NEPT has gained $0.06 from the previous closing price of $2.84 on volume of 80,929 shares. Over the past year the S&P 500 has gained 1.51% while NEPT is lower by -32.87%. NEPT lost -$0.07 per share the over the last 12 months.

To screen for more stocks like NEPT click here.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

40% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 57% with annual

InvestorsObserver Premium

$ 20.75 $ 12.45 /month
$249 $149.40 billed annually

You May Also Like

Related Articles

Related Companies